Skip to main content

GMed Grand Rounds | GileadPro

getty-images-1327475879
Events

Gilead Medical Education Grand Rounds

UK and Ireland

Monthly

Gilead Sciences welcomes you to join us virtually for the monthly webinar series, Gilead Medical Education Grand Rounds.


What is the Gilead Medical Education Grand Rounds?
It is a programme of non-promotional virtual, case-based meetings funded and organised by Gilead, featuring a different expert health care professional (HCP) each month, held on a weekday evening, and lasting 1 hour. The expert will deliver an interactive session utilising patient case studies, primarily focusing on current treatment paradigms within breast cancer care. Continuing professional development (CPD) accreditation will be sought for these meetings. This programme is for healthcare professionals only.

What topics will be covered?
Previous breast cancer topics covered during the webinars have included, among others: treatment options in HER2-positive disease, the impact of comorbidities on treatment, and fertility and pregnancy. Please see below for a comprehensive list. Future sessions will continue to focus on topical clinical issues in breast cancer.

How will the sessions be interactive?
There will be online polls and Q&As for you to participate in, as well as an opportunity to ask your questions to the expert presenter of the month.

How can I be notified about future events?
To find out about future events, please click here to register your consent to receive Gilead communications. Know a HCP colleague who might be interested in joining? Please share this link to let them know about the Gilead Medical Education Grand Rounds programme.

How do I register for an event?
You should receive an email invitation to the next session after signing up for Gilead communications; click the Zoom webinar registration link to secure your place. Please make sure you can access the Zoom platform before the session starts. If you have any questions, please contact the webinar host at [email protected].

Previous topics covered:

  • Did IVF cause my breast cancer?
  • Treatment options in HER2 positive breast cancer
  • Hormone-dependent metastatic breast cancer - treatment choices, including genomic based personalised treatments
  • The integrative oncology approach to cancer treatment; when conventional meets complementary medicine
  • Managing breast cancer in challenging scenarios; elderly patients and the impact of serious co-morbidities
  • Fertility and pregnancy following breast cancer
  • De novo and relapsed metastatic breast cancer: similarities and differences in incidence, outcomes in clinical practice and impact on clinical trials
  • Treatment Options in Early TNBC
  • Communicating vast amounts of medicines information to patients in a limited time frame; case based examples

January 2024 UK-UNB-3383

Adverse events should be reported

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead to [email protected] or +44 (0) 1223 897500.